Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2025-12-26 @ 2:42 PM
NCT ID:
NCT02281006
Eligibility Criteria:
Inclusion Criteria:
* Patients with newly diagnosed locally advanced (stage III or IV) squamous cell carcinoma of the mouth, oropharynx, hypopharynx, or larynx scheduled to be treated with concomitant chemoradiation including Cisplatin100 mg/m2 3 times
* Normal otoscopic findings and symmetrical hearing
Exclusion Criteria:
* Karnofsky below 70
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02281006
Study Brief:
Protocol Section:
NCT02281006